Open access
1,985
Views
1
CrossRef citations to date
0
Altmetric
Report
CC-96673 (BMS-986358), an affinity-tuned anti-CD47 and CD20 bispecific antibody with fully functional fc, selectively targets and depletes non-Hodgkin’s lymphoma
Dan Zhua Department of Discovery Biotherapeutics, Bristol Myers Squibb, San Diego, CA, USACorrespondence[email protected]
View further author information
, View further author information
Haralambos Hadjivassilioua Department of Discovery Biotherapeutics, Bristol Myers Squibb, San Diego, CA, USAView further author information
, Catherine Jenningsa Department of Discovery Biotherapeutics, Bristol Myers Squibb, San Diego, CA, USAView further author information
, David Mikolona Department of Discovery Biotherapeutics, Bristol Myers Squibb, San Diego, CA, USAView further author information
, Massimo Ammiranteb Oncogenesis Thematic Research Center, Bristol Myers Squibb, San Diego, CA, USAView further author information
, Sharmistha Acharyaa Department of Discovery Biotherapeutics, Bristol Myers Squibb, San Diego, CA, USAView further author information
, Jon Lloyda Department of Discovery Biotherapeutics, Bristol Myers Squibb, San Diego, CA, USAView further author information
, Mahan Abbasiana Department of Discovery Biotherapeutics, Bristol Myers Squibb, San Diego, CA, USAView further author information
, Rama Krishna Narlab Oncogenesis Thematic Research Center, Bristol Myers Squibb, San Diego, CA, USAView further author information
, Joseph R. Piccottic Department of Nonclinical Development, Bristol Myers Squibb, San Diego, CA, USAView further author information
, Katie Stampc Department of Nonclinical Development, Bristol Myers Squibb, San Diego, CA, USAView further author information
, Ho Choa Department of Discovery Biotherapeutics, Bristol Myers Squibb, San Diego, CA, USAView further author information
& Kandasamy Hariharana Department of Discovery Biotherapeutics, Bristol Myers Squibb, San Diego, CA, USAView further author information
show all
Article: 2310248
|
Received 16 Oct 2023, Accepted 22 Jan 2024, Published online: 13 Feb 2024
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.